Q1 EARNINGS: JnJ bullish in spite of device slump
Johnson & Johnson’s medical device division was again a weak link: revenues from the division fell 11% in its first quarter, to $6.26bn.
Johnson & Johnson’s medical device division was again a weak link: revenues from the division fell 11% in its first quarter, to $6.26bn.